196 related articles for article (PubMed ID: 38527038)
1. Combination of ethyl acetate fraction from Calotropis gigantea stem bark and sorafenib induces apoptosis in HepG2 cells.
Chaisupasakul P; Pekthong D; Wangteeraprasert A; Kaewkong W; Somran J; Kaewpaeng N; Parhira S; Srisawang P
PLoS One; 2024; 19(3):e0300051. PubMed ID: 38527038
[TBL] [Abstract][Full Text] [Related]
2. Cucurbitacin E shows synergistic effect with sorafenib by inducing apoptosis in hepatocellular carcinoma cells and regulates Jak/Stat3, ERK/MAPK, PI3K/Akt/mTOR signaling pathways.
Üremiş MM; Üremiş N; Türköz Y
Steroids; 2023 Oct; 198():109261. PubMed ID: 37355001
[TBL] [Abstract][Full Text] [Related]
3. Kaempferol inhibits proliferation, migration, and invasion of liver cancer HepG2 cells by down-regulation of microRNA-21.
Zhu G; Liu X; Li H; Yan Y; Hong X; Lin Z
Int J Immunopathol Pharmacol; 2018; 32():2058738418814341. PubMed ID: 30477356
[TBL] [Abstract][Full Text] [Related]
4. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
[TBL] [Abstract][Full Text] [Related]
5.
Suknoppakit P; Wangteeraprasert A; Simanurak O; Somran J; Parhira S; Pekthong D; Srisawang P
Heliyon; 2023 May; 9(5):e16375. PubMed ID: 37251821
[TBL] [Abstract][Full Text] [Related]
6. Preclinical efficacy of a novel dual PI3K/mTOR inhibitor, CMG002, alone and in combination with sorafenib in hepatocellular carcinoma.
Kim MN; Lee SM; Kim JS; Hwang SG
Cancer Chemother Pharmacol; 2019 Oct; 84(4):809-817. PubMed ID: 31385002
[TBL] [Abstract][Full Text] [Related]
7. Calotropis Procera Induced Caspase-Dependent Apoptosis and Impaired Akt/mTOR Signaling in 4T1 Breast Cancer Cells.
Rabelo ACS; Miglino MA; Arbizu S; Carreira ACO; Filho AJC; Carneiro FJC; Layosa MAA; Noratto G
Anticancer Agents Med Chem; 2022; 22(18):3136-3147. PubMed ID: 35676853
[TBL] [Abstract][Full Text] [Related]
8. Calotropis gigantea stem bark extracts inhibit liver cancer induced by diethylnitrosamine.
Sawong S; Pekthong D; Suknoppakit P; Winitchaikul T; Kaewkong W; Somran J; Intapa C; Parhira S; Srisawang P
Sci Rep; 2022 Jul; 12(1):12151. PubMed ID: 35840761
[TBL] [Abstract][Full Text] [Related]
9. Single Agent and Synergistic Activity of the "First-in-Class" Dual PI3K/BRD4 Inhibitor SF1126 with Sorafenib in Hepatocellular Carcinoma.
Singh AR; Joshi S; Burgoyne AM; Sicklick JK; Ikeda S; Kono Y; Garlich JR; Morales GA; Durden DL
Mol Cancer Ther; 2016 Nov; 15(11):2553-2562. PubMed ID: 27496136
[TBL] [Abstract][Full Text] [Related]
10. Capsaicin and sorafenib combination treatment exerts synergistic anti‑hepatocellular carcinoma activity by suppressing EGFR and PI3K/Akt/mTOR signaling.
Dai N; Ye R; He Q; Guo P; Chen H; Zhang Q
Oncol Rep; 2018 Dec; 40(6):3235-3248. PubMed ID: 30272354
[TBL] [Abstract][Full Text] [Related]
11. Itraconazole exerts anti-liver cancer potential through the Wnt, PI3K/AKT/mTOR, and ROS pathways.
Wang W; Dong X; Liu Y; Ni B; Sai N; You L; Sun M; Yao Y; Qu C; Yin X; Ni J
Biomed Pharmacother; 2020 Nov; 131():110661. PubMed ID: 32942154
[TBL] [Abstract][Full Text] [Related]
12. Synergistic antitumor effect of BRMS1 and sorafenib via inhibition of the PI3K/AKT/mTOR/ERK signaling pathway.
Jin J; Guo Y; Liu Y; Wang Z; Yang X; Sun S
Oncol Rep; 2019 Sep; 42(3):1183-1193. PubMed ID: 31233204
[TBL] [Abstract][Full Text] [Related]
13. Calotropis gigantea stem bark extract induced apoptosis related to ROS and ATP production in colon cancer cells.
Winitchaikul T; Sawong S; Surangkul D; Srikummool M; Somran J; Pekthong D; Kamonlakorn K; Nangngam P; Parhira S; Srisawang P
PLoS One; 2021; 16(8):e0254392. PubMed ID: 34343190
[TBL] [Abstract][Full Text] [Related]
14. Anti-breast cancer and toxicity studies of total secondary saponin from Anemone raddeana Rhizome on MCF-7 cells via ROS generation and PI3K/AKT/mTOR inactivation.
Zhang D; Zhang Q; Zheng Y; Lu J
J Ethnopharmacol; 2020 Sep; 259():112984. PubMed ID: 32446927
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cancer cell growth by oleanolic acid in multidrug resistant liver carcinoma is mediated via suppression of cancer cell migration and invasion, mitochondrial apoptosis, G2/M cell cycle arrest and deactivation of JNK/p38 signalling pathway.
Gao C; Li X; Yu S; Liang L
J BUON; 2019; 24(5):1964-1969. PubMed ID: 31786862
[TBL] [Abstract][Full Text] [Related]
16. CXC195 induces apoptosis and endoplastic reticulum stress in human hepatocellular carcinoma cells by inhibiting the PI3K/Akt/mTOR signaling pathway.
Chen XL; Fu JP; Shi J; Wan P; Cao H; Tang ZM
Mol Med Rep; 2015 Dec; 12(6):8229-36. PubMed ID: 26496900
[TBL] [Abstract][Full Text] [Related]
17. Ropivacaine suppresses tumor biological characteristics of human hepatocellular carcinoma via inhibiting IGF-1R/PI3K/AKT/mTOR signaling axis.
Zhang R; Lian Y; Xie K; Cai Y; Pan Y; Zhu Y
Bioengineered; 2021 Dec; 12(2):9162-9173. PubMed ID: 34696683
[TBL] [Abstract][Full Text] [Related]
18. Puerarin 6″-O-xyloside suppressed HCC via regulating proliferation, stemness, and apoptosis with inhibited PI3K/AKT/mTOR.
Li L; Liu JD; Gao GD; Zhang K; Song YW; Li HB
Cancer Med; 2020 Sep; 9(17):6399-6410. PubMed ID: 32691991
[TBL] [Abstract][Full Text] [Related]
19. C2-ceramide enhances sorafenib-induced caspase-dependent apoptosis via PI3K/AKT/mTOR and Erk signaling pathways in HCC cells.
Jiang S; Wang Q; Feng M; Li J; Guan Z; An D; Dong M; Peng Y; Kuerban K; Ye L
Appl Microbiol Biotechnol; 2017 Feb; 101(4):1535-1546. PubMed ID: 27807662
[TBL] [Abstract][Full Text] [Related]
20. SKI-349, a Sphingosine Kinases 1/2 Inhibitor, Suppresses Cell Viability, Invasion, and AKT/mTOR Signaling Pathway, and Shows Synergistic Cytotoxic Effects with Sorafenib in Hepatocellular Carcinoma.
Chen L; Wang L; Han Z; Qin P; Niu G; Du J
Tohoku J Exp Med; 2024 Mar; 262(3):173-180. PubMed ID: 38123304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]